Ascorbylperoxide contaminating parenteral nutrition perturbs the lipid metabolism in newborn guinea pig.
The light exposure of parenteral nutritive solutions generates peroxides such as H(2)O(2) and ascorbylperoxide [2,3-diketo-4-hydoxyperoxyl-5,6-dihydroxyhexanoic acid]. This absence of photoprotection is associated with higher plasma triacylglycerol (TG) concentration in premature infants and oxidative stress and H(2)O(2)-independent hepatic steatosis in animals. We hypothesized that ascorbylperoxide is the active agent leading to high TG. The aim was to investigate the role of ascorbylperoxide in glucose and lipid metabolism in an animal model of neonatal parenteral nutrition. Three-day-old guinea pigs received through a catheter in the jugular solutions containing dextrose plus 0, 90, 225, or 450 microM ascorbylperoxide. After 4 days, blood and liver were sampled and treated for determinations of TG, cholesterol, markers of oxidative stress (redox potential of glutathione and F(2alpha)-isoprostane), and activities and protein levels of acetyl-CoA carboxylase (ACC), glucokinase, and phosphofructokinase (PFK). Ascorbylperoxide concentration was measured in urine on the last day. Data were compared by analysis of variance (p < 0.05). Plasma TG and cholesterol and hepatic PFK activity increased (200% of control), whereas ACC activity decreased (66% of control) in the function of the amount of ascorbylperoxide infused. Both markers of oxidative stress were higher in animals receiving the highest amounts of ascorbylperoxide. The logarithmic relations between urinary ascorbylperoxide and plasma TG (r(2) = 0.69) and hepatic PFK activity (r(2) = 0.26) were positive, whereas they were negative with ACC activity (r(2) = 0.50). In conclusion, ascorbylperoxide contaminating parenteral nutrition stimulates glycolysis, allowing higher availability of substrates for lipid synthesis. The logarithmic relation between urinary ascorbylperoxide and plasma TG suggests a very low efficient concentration.
Maghdessian
Raffi
R
Department of Nutrition, Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, QC, Canada.
Côté
François
F
Rouleau
Thérèse
T
Ben Djoudi Ouadda
Ali
A
Levy
Emile
E
Lavoie
Jean-Claude
JC
D000103:Acetyl-CoA Carboxylase / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D001205:Ascorbic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000652:urine; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D005941:Glucokinase / Q000378:metabolism; D006168:Guinea Pigs; D008027:Light; D050356:Lipid Metabolism / Q000187:drug effects*; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000187:drug effects*; D010288:Parenteral Nutrition / Q000592:standards*; D010545:Peroxides / Q000009:adverse effects* / Q000652:urine; D025221:Phosphofructokinases / Q000378:metabolism; D014280:Triglycerides / Q000097:blood / Q000378:metabolism; D014815:Vitamins / Q000737:chemistry / Q000528:radiation effects
D010545:Peroxides; D014280:Triglycerides; D014815:Vitamins; C550723:ascorbylperoxide; D002784:Cholesterol; D025221:Phosphofructokinases; D005941:Glucokinase; D000103:Acetyl-CoA Carboxylase; D001205:Ascorbic Acid